Popular
This Week This Month
Storyboards
Sign In
to Vote &
Create Storyboards.
 

Experimental drug more effective in treating rare kidney disease

Science Daily - 25 Oct 2018 20:19
New study finds that experimental drug sparsentan is an effective treatment for the rare kidney disease focal segmental glomerulosclerosis, which currently has no FDA-approved therapies.
Full Article at Science Daily

More Science News
1
0
0


Storyboard
Print
Share this Article

Recommended

  • {TITLE}     {PUBLISHER} - {PUBLISHED_DATE}
    {VIEWS}

    • Create Storyboard